Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,305 public trials 1,293 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer

NCT03936465

Conditions
Brain Diseases, Brain Neoplasms, Brain Tumor, Pediatric, +26 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • C.S. Mott Children's Hospital Ann Arbor, Michigan, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies

NCT01794793

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +50 more
Locations
  • Ximed Research SC - SOM230B2412 La Jolla, California, United States
  • Cedars Sinai Medical Center Cedars Sinai 4 Los Angeles, California, United States
  • Stanford Universtiy Medical Center Stanford Hospital & Clinics Stanford, California, United States
  • University of Michigan Comprehensive Cancer Center SC-2 Ann Arbor, Michigan, United States
View all 94 locations
View Trial Details
Completed

A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors

NCT02791334

Conditions
Breast Cancer (HR+HER2-), Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • The START Center for Cancer Care San Antonio, Texas, United States
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
View all 14 locations
View Trial Details
Completed

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

NCT03864042

Conditions
Advanced Solid Tumors, Melanoma, Metastatic Melanoma, +11 more
Locations
  • UC Irvine Health Orange, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States
  • University of Illinois at Chicago Chicago, Illinois, United States
  • Hopkins Eye Clinic Hopkins, Minnesota, United States
View all 29 locations
View Trial Details
Completed

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced Non-melanoma Skin Cancers

NCT04160065

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +16 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Huntsman Cancer Institute Salt Lake City, Utah, United States
View Trial Details

Related conditions